A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas

Clinical trial NCT01445119 · COMPLETED

Trial details

NCT number: NCT01445119
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Gliomas

Start date: 2007-01-01
Primary completion: 2013-07-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.